Biochemistry, structure, and cellular internalization of a four nanobody‐bearing Fc dimer

DOI Web Site Web Site 被引用文献1件
  • Eric Chabrol
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Charline Fagnen
    Sorbonne Université, UMR 7590, CNRS, Muséum National d'Histoire Naturelle, IRD Institut de Minéralogie, Physique des Matériaux et de Cosmochimie, IMPMC Paris France
  • Sophie Landron
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Estelle Marcheteau
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Johann Stojko
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Sophie‐Pénélope Guenin
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Mathias Antoine
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Benjamin Fould
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Gilles Ferry
    Pole d'Expertise Biotechnologie, Chimie, Biologie Institut de Recherches Servier Croissy‐sur‐Seine France
  • Jean A. Boutin
    Institut de Recherches Internationales Servier Suresnes Cedex France
  • Catherine Vénien‐Bryan
    Sorbonne Université, UMR 7590, CNRS, Muséum National d'Histoire Naturelle, IRD Institut de Minéralogie, Physique des Matériaux et de Cosmochimie, IMPMC Paris France

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>VHH stands for the variable regions of heavy chain only of camelid IgGs. The VHH family forms a set of interesting proteins derived from antibodies that maintain their capacity to recognize the antigen, despite their relatively small molecular weight (in the 12,000 Da range). Continuing our exploration of the possibilities of those molecules, we chose to design alternative molecules with maintained antigen recognition, but enhanced capacity, by fusing four VHH with one Fc, the fragment crystallizable region of antibodies. In doing so, we aimed at having a molecule with superior quantitative antigen recognition (×4) while maintaining its size below the 110 kDa. In the present paper, we described the building of those molecules that we coined VHH<jats:sub>2</jats:sub>‐Fc‐VHH<jats:sub>2</jats:sub>. The structure of VHH<jats:sub>2</jats:sub>‐Fc‐VHH<jats:sub>2</jats:sub> in complex with HER2 antigen was determined using electronic microscopy and modeling. The molecule is shown to bind four HER2 proteins at the end of its flexible arms. VHH<jats:sub>2</jats:sub>‐Fc‐VHH<jats:sub>2</jats:sub> also shows an internalization capacity via HER2 receptor superior to the reference anti‐HER2 monoclonal antibody, Herceptin®, and to a simple fusion of two VHH with one Fc (VHH<jats:sub>2</jats:sub>‐Fc). This new type of molecules, VHH<jats:sub>2</jats:sub>‐Fc‐VHH<jats:sub>2</jats:sub>, could be an interesting addition to the therapeutic arsenal with multiple applications, from diagnostic to therapy.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ